Theresa A Boyle

16PUBLICATIONS
85CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesPredictive and prognostic markersCellular immunologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|Aug 05, 2026
Nongenetic Factors Associated With Onset and Severity of Hereditary Ataxia.

|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

|Jan 26, 2026
ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin.

Misty D Shields, Katherine G Minton, Hilal Ozakinci

|Dec 19, 2025
Distinct Tumor-Immune Ecologies in Patients with Lung Cancer Predict Progression and Define a Clinical Biomarker of Therapy Response.

Sandhya Prabhakaran, Chandler D Gatenbee, Mark Robertson-Tessi

|May 09, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy.

Chao Wang, Xiaoqing Yu, Jamie K Teer

Pageof 3

Frequent Collaborators

4 joint publications

Alexander R Anderson

3 joint publications

Andriy Marusyk

3 joint publications

Amer A Beg

3 joint publications

Brian Ruffell